International Reviews of Immunology

Papers
(The TQCC of International Reviews of Immunology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Transforming growth factor-β in tumor microenvironment: Understanding its impact on monocytes and macrophages for its targeting36
Breaking the graft-versus-host-disease barrier: Mesenchymal stromal/stem cells as precision healers34
Chemokines: A key driver for inflammation in protozoan infection31
Phagosomal escape and sabotage: The role of ESX-1 and PDIMs in Mycobacterium tuberculosis pathogenesis29
The role of tumor-infiltrating B cells in the development and pathogenesis of head and neck cancers: Implications for therapeutic approach24
The molecular landscape of T cell exhaustion in the tumor microenvironment and reinvigoration strategies23
Understanding the role of regulatory T cell-derived small extracellular vesicles in suppression of anti-tumor immune response: Key to advancing cancer immunotherapy19
B cell antigens: A key to optimizing CAR-T cell therapy18
Natural antigen landscape shaping intestinal Treg cells: Self, diet, and microbiota17
An insight into COVID-19 host immunity at single-cell resolution17
Exploring the role of neutrophils in infectious and noninfectious pulmonary disorders17
Th17 cells: A new target in kidney disease research16
Antibody-drug conjugates in breast cancer: From therapeutic and immune activation mechanisms to resistance prevention13
Mitochondria in the immune system: Therapeutic potential from mitochondria transfer12
Immunological processes of enhancers and suppressors of long non-coding RNAs associated with brain tumors and inflammation12
The NLRP3 inflammasome: Mechanisms of activation, regulation, and role in diseases12
Retraction10
Gut microbiome as a treatment in colorectal cancer9
Revolutionizing IBD therapy: Insights into contemporary treatment strategies9
FUNDC1 mediated mitochondria-dependent ferroptosis of epithelial cells in model of asthma by FBXL2/ar/GPX4 signaling pathway of SUMO1 at K1369
B7-H3-targeted CAR-T cell therapy for solid tumors9
1.2365190982819